Betahistin-Mepha 16, Tabletten
7680581240014
CH-58124
Tabletten
Associated product:
BETAHISTIN Mepha cpr 16 mg 50 pce
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
16.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
140.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 13.85
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2008
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 58124
- Drug name
- Betahistin-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- N07CA01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 29/10/2007
- Authorization expiration date
- 31/12/9999
- IT Number
- 02.04.4.
- Domain
- Human medicine
Package details
- Description (FR)
- BETAHISTIN Mepha cpr 16 mg 50 pce
- Description (DE)
- BETAHISTIN Mepha Tabl 16 mg 50 Stk
- Market launch
- 29/10/2007
- Narcotic (BTM)
- No
Original drug
Betaserc, Tabletten
GTIN: 7680361190126
CHF 13.25